The Journal of infectious diseases.

Periodical
Communicable Diseases
Publisher:
University of Chicago Press. Oxford : Oxford University Press (2011)
Frequency: Twenty four no. a year, 2001-
Country: United States
Language: English
Author(s):
John McCormick Institute for Infectious Diseases., John Rockefeller McCormick Memorial Fund., Memorial Institute for Infectious Diseases (Chicago, Ill.), Infectious Diseases Society of America.
Start Year:1904 -
ISSN:
0022-1899 (Print)
1537-6613 (Electronic)
0022-1899 (Linking)
Impact Factor
6.4
2022
NLM ID:0413675
(DNLM):J24240000(s)
(OCoLC):01754628
Coden:JIDIAQ
LCCN:a 40001288
Classification:W1 JO707
Correction to: Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
The Journal of infectious diseases    September 22, 2022   Volume 227, Issue 7 926 doi: 10.1093/infdis/jiac374
No abstract available
Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
The Journal of infectious diseases    August 4, 2022   Volume 227, Issue 1 35-39 doi: 10.1093/infdis/jiac331
Luczkowiak J, Radreau P, Nguyen L, Labiod N, Lasala F, Veas F, Herbreteau CH, Delgado R.Several anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs) have received emergency authorization for coronavirus disease 2019 (COVID-19) treatment. However, most of these mAbs are not active against the highly mutated Omicron SARS-CoV-2 subvariants. We have tested a polyclonal approach of equine anti-SARS-CoV-2 F(ab')2 antibodies that achieved a high level of neutralizing potency against all SARS-CoV-2 variants of concern tested including Omicron BA.1, BA.2, BA.2.12 and BA.4/5. A repertoire of antibodies targeting conserved epitopes in different regi...
In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab’)2.
The Journal of infectious diseases    March 11, 2019   Volume 220, Issue 1 41-45 doi: 10.1093/infdis/jiz068
Racine T, Denizot M, Pannetier D, Nguyen L, Pasquier A, Raoul H, Saluzzo JF, Kobinger G, Veas F, Herbreteau CH.There is no vaccine or approved therapy against lethal Ebola virus (EBOV). We investigated a proven technology platform to produce polyclonal IgG fragments, F(ab')2, against EBOV. Horses immunized with nanoparticles harboring surface glycoprotein trimers of EBOV-Zaire/Makona produced anti-Ebola IgG polyclonal antibodies with high neutralization activity. Highly purified equine anti-Ebola F(ab')2 showed strong cross-neutralization of 2 Zaire EBOV strains (Gabon 2001 and Makona) and in vivo 3 or 5 daily F(ab')2 intraperitoneal injections provided 100% protection to BALB/c mice against lethal EBO...
A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease.
The Journal of infectious diseases    May 22, 2009   Volume 200, Issue 1 20-25 doi: 10.1086/599316
Van de Walle GR, Goupil R, Wishon C, Damiani A, Perkins GA, Osterrieder N.Epidemiological studies have shown that a single-nucleotide polymorphism in the equid herpesvirus type 1 DNA polymerase gene is associated with outbreaks of highly lethal neurological disease in horses. Reverse genetics experiments further demonstrated that a G(2254) A(2254) nucleotide mutation introduced in neurovirulent strain Ab4, which resulted in an asparagine for aspartic acid substitution (D(752) N(752)), rendered the virus nonneurovirulent in the equine. Here, we report that the nonneurovirulent strain equid herpesvirus type 1 strain NY03 caused lethal neurological disease in horses af...
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.
The Journal of infectious diseases    February 13, 1999   Volume 179 Suppl 1 S224-S234 doi: 10.1086/514310
Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peters CJ.A passive immunization strategy for treating Ebola virus infections was evaluated using BALB/ c mice, strain 13 guinea pigs, and cynomolgus monkeys. Guinea pigs were completely protected by injection of hyperimmune equine IgG when treatment was initiated early but not after viremia had developed. In contrast, mice were incompletely protected even when treatment was initiated on day 0, the day of virus inoculation. In monkeys treated with one dose of IgG on day 0, onset of illness and viremia was delayed, but all treated animals died. A second dose of IgG on day 5 had no additional beneficial e...
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California.
The Journal of infectious diseases    October 23, 1997   Volume 176, Issue 4 1029-1034 doi: 10.1086/516529
Asanovich KM, Bakken JS, Madigan JE, Aguero-Rosenfeld M, Wormser GP, Dumler JS.The agent of human granulocytic ehrlichiosis (HGE), Ehrlichia phagocytophila, and Ehrlichia equi are very similar. HGE is of variable severity. Genetic and antigenic differences among 3 human isolates (Webster, Spooner, and NY-8) and 1 horse isolate (MRK) were evaluated. The 16S rRNA gene sequences were identical in all human isolates. By use of 5 homologous antisera from these 3 humans and 1 horse and an additional 5 antisera in heterologous reactions, the immunodominant antigens of each isolate were noted to differ in molecular size: 43 kDa in the Webster (Wisconsin) isolate, 46 kDa in the S...
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995.
The Journal of infectious diseases    April 1, 1997   Volume 175, Issue 4 828-832 doi: 10.1086/513978
Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Caceres FM, Aristizabal G, Martinez JW, Revelo D, De la Hoz F, Boshell J....In 1995, the first Venezuelan equine encephalitis (VEE) outbreak in Colombia in 22 years caused an estimated 75,000 human cases, 3000 with neurologic complications and 300 fatal, in La Guajira State. Of the state's estimated 50,000 equines, 8% may have died. An epizootic IC virus, probably introduced from Venezuela, was rapidly amplified among unvaccinated equines. Record high rainfall, producing high densities of vector Aedes taeniorhynchus, led to extensive epidemic transmission (30% attack rate) in the four affected municipalities. Native Wayuu Indians, constituting 24% of the state's popul...
Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation.
The Journal of infectious diseases    September 1, 1991   Volume 164, Issue 3 515-521 doi: 10.1093/infdis/164.3.515
McCoy HE, Broder CC, Lottenberg R.The species specificities of plasminogen activation and binding of plasmin by pathogenic group C streptococci isolated from humans, horses, and pigs were examined. Of 56 streptococcal isolates, 52 elaborated plasminogen activator activity and 49 of these had specificity for plasminogen of the homologous host. Analysis of supernatants from 13 isolates indicated that the plasminogen activator activity resulted from secreted streptokinases. These 13 streptokinases were antigenically related and bound all three plasminogens, indicating that the binding recognition sites were conserved despite the ...
Ehrlichiosis–a disease of animals and humans.
The Journal of infectious diseases    April 1, 1990   Volume 161, Issue 4 609-617 doi: 10.1093/infdis/161.4.609
McDade JE.Ehrlichiae are one of several kinds of obligate intracellular bacteria. Taxonomically, they are grouped with rickettsiae, but they can be distinguished by their unique tropism for circulating leukocytes. Ehrlichia canis causes a pancytopenia in dogs that becomes chronic if untreated. Certain breeds develop severe infections, characterized by fever, anorexia, dramatic weight loss, marked pancytopenia, anemia, peripheral edema, and hemorrhage. Ehrlichia risticii, a recently discovered species, is the cause of a serious diarrheal disease of horses. Other species of ehrlichiae have been documented...
Streptococcus durans: an unexpected enteropathogen of foals.
The Journal of infectious diseases    October 1, 1984   Volume 150, Issue 4 589-593 doi: 10.1093/infdis/150.4.589
Tzipori S, Hayes J, Sims L, Withers M.Streptococcus durans was isolated from a foal with profuse watery diarrhea and caused a similar syndrome when inoculated into foals via the orogastric route. The most consistent and striking histological feature was the extensive colonization of the mucosal surface of the small intestine by S. durans. Associated mucosal changes were mild to modeate, and brush border lactase and alkaline phosphatase production were depressed. S. durans also induced acute diarrhea in young gnotobiotic piglets. Mucosal changes were mild and, as with foals, the mucosal surface of the small intestine was colonized ...
Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
The Journal of infectious diseases    September 1, 1984   Volume 150, Issue 3 407-412 doi: 10.1093/infdis/150.3.407
Hatheway CH, Snyder JD, Seals JE, Edell TA, Lewis GE.Serum levels of equine-botulism antitoxin to toxin types A, B, and E were measured in four type-A botulism patients who had received equine-botulism antitoxin. High circulating levels capable of neutralizing in excess of 1 X 10(8), 9 X 10(7), and 6 X 10(6) 50% mouse lethal doses of toxin of types A, B, and E, respectively, were detected. There was little depletion of type-A antitoxin even though two of the patients had circulating type-A toxin before treatment. The half-life for antitoxin persistence for one patient was calculated as being 6.5, 7.6, and 5.3 days for antitoxin types A, B, and E...
Enzootic and epizootic Venezuelan equine encephalomyelitis virus in horses infected by peripheral and intrathecal routes.
The Journal of infectious diseases    March 1, 1978   Volume 137, Issue 3 227-237 doi: 10.1093/infdis/137.3.227
Dietz WH, Alvarez O, Martin DH, Walton TE, Ackerman LJ, Johnson KM.Forty-five horses were infected peripherally or intrathecally with enzootic or epizootic strains of Venezuelan equine encephalomyelitis (VEE) virus. Low titers of virus appeared in cerebrospinal fluid (CSF) after peripheral inoculation of enzootic or epizootic VEE virus strains. Intrathecal infection with either epizootic or enzootic VEE virus produced higher titers of virus in CSF than did peripheral infection. In contrast to peripheral infections with enzootic strains, intrathecal infections with these strains caused death. The animals that died had widespread histopathologic changes and lar...
Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus.
The Journal of infectious diseases    September 1, 1973   Volume 128, Issue 3 271-282 doi: 10.1093/infdis/128.3.271
Walton TE, Alvarez O, Buckwalter RM, Johnson KM.No abstract available
Equine interferon: absence in equine infectious anemia and kinetics of induction in equine cells.
The Journal of infectious diseases    July 1, 1970   Volume 122, Issue 1 10-15 doi: 10.1093/infdis/122.1-2.10
Ley KD, Burger D, McGuire T, Henson JB.The role of interferon in the pathogenesis of per- sistent or chronic viral diseases has not been elu- cidated. However, interferon or inducers of inter- feron may have a marked effect on the course of certain chronic viral diseases [1-3]. Equine infec- tious anemia (EIA) is a viral disease of horses that may take an inapparent, acute, subacute, or chronic course in the affected host [4]. Chronically infected horses suffer from recurrent attacks of fever that are accompanied by severe anemia. After the infection has been established, infected horses may carry the virus for the rest ...
Equine interferon: characterization of a viral inhibitor induced in equine kidney cell cultures with statolon.
The Journal of infectious diseases    March 1, 1970   Volume 121, Issue 3 335-338 doi: 10.1093/infdis/121.3.335
Ley KD, Burger D, Henson JB.No abstract available
Behavior of equine infectious anemia virus in cell culture and development of a diagnostic test for the disease.
The Journal of infectious diseases    December 1, 1968   Volume 118, Issue 5 473-480 doi: 10.1093/infdis/118.5.473
el-Zein A, Myers WL, Segre D.No abstract available
Factors Affecting Plaque Formation by the Infectious Ribonucleic Acid of the Equine Encephalitis Viruses.
The Journal of infectious diseases    February 1, 1964   Volume 114 61-68 doi: 10.1093/infdis/114.1.61
COLON JI, IDOINE JB.No abstract available
Hyperimmunized horse anti-B virus globulin: preparation and effectiveness.
The Journal of infectious diseases    September 1, 1962   Volume 111 101-106 doi: 10.1093/infdis/111.2.101
BUTHALA DA.No abstract available
The reaction of sensitized horse erythrocytes with rheumatoid arthritis serum.
The Journal of infectious diseases    September 1, 1962   Volume 111 141-145 doi: 10.1093/infdis/111.2.141
PIKE RM, SCHULZE ML.No abstract available
The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts.
The Journal of infectious diseases    January 1, 1962   Volume 110 80-97 doi: 10.1093/infdis/110.1.80
GLEISER CA, GOCHENOUR WS, BERGE TO, TIGERTT WD.No abstract available
Application of the paper disc technique to the collection of whole blood and serum samples in studies on eastern equine encephalomyelitis.
The Journal of infectious diseases    November 1, 1957   Volume 101, Issue 3 295-299 doi: 10.1093/infdis/101.3.295
KARSTAD L, SPALATIN J, HANSON RP.No abstract available
Interference between St. Louis encephalitis virus and Western equine encephalomyelitis virus along a neuronal pathway.
The Journal of infectious diseases    September 1, 1952   Volume 91, Issue 2 165-172 doi: 10.1093/infdis/91.2.165
JORDAN RT, DUFFY CE.No abstract available
Effect of pituitary adreno-corticotrophic hormone (ACTH) on experimental poliomyelitis and equine encephalomyelitis.
The Journal of infectious diseases    January 1, 1951   Volume 88, Issue 1 54-55 doi: 10.1093/infdis/88.1.54
MILZER A.No abstract available
Studies on equine encephalomyelitis in Michigan.
The Journal of infectious diseases    July 1, 1947   Volume 81, Issue 1 48-54 doi: 10.1093/infdis/81.1.48
BROWN GC.No abstract available